SpringWorks Therapeutics Inc (SWTX) Down 30.85% in Premarket Trading

SpringWorks Therapeutics Inc (SWTX) is down Friday morning, with the stock falling -30.85% in pre-market trading to 21.32. SWTX's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, SWTX ranks higher than 9% of stocks. SpringWorks Therapeutics Inc has fallen 31.75% over the past month, closing at $42.91 on April 29. During this period of time, the stock fell as low as $32.67 and as high as $51.04. SWTX has an average analyst recommendation of Strong Buy. The company has an average price target of $113.75.

SWTX has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on SWTX!

See Full SWTX Report

SpringWorks Therapeutics Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 143 by this metric, SWTX ranks better than 143% of stocks.

Important Dates for Investors in SWTX:

-SpringWorks Therapeutics Inc is set to release earnings on 8/3/2022. Over the last 12 months, the company has reported EPS of $-4.23. -We do not have a set dividend date for SpringWorks Therapeutics Inc at this time. Click Here To Get The Full Report on SpringWorks Therapeutics Inc (SWTX)